COMP <GO>
ROK vs TMO // RSI-14 & 200D SMA MOMENTUM
Rockwell Automation Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: ROK 7
— TMO 8
▲ RSI-14 & 200D SMA MOMENTUM LEADER: TMO
LAST: $436.20 (-3.37%) • MKT CAP: $50.23B
rsi-technicals
51.2
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
rsi-technicals
59.1
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ROK VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ROK | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 48.10% | 41.00% | +7.10 | ROK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 22.90% | 9.30% | +13.60 | ROK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 25.9x | 30.4x | -4.50 | ROK | /valuation <GO> |
| Free Cash Flow Yield | 2.33% | 2.40% | -0.07 | TMO | /fcf-yield <GO> |
| Operating Margin | 20.40% | 17.40% | +3.00 | ROK | /operating-margins <GO> |
| Net Profit Margin | 10.40% | 15.10% | -4.70 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 0.90% | 3.90% | -3.00 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.18% | 0.24% | +0.94 | ROK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.59 | 4.50 | +3.09 | ROK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 6.70% | +0.50 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 51.2 | 59.1 | -7.95 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.10 | 0.94 | +0.16 | ROK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 53.8x | 36.3x | +17.50 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $50.23B | $262.22B | -$211.99B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ROK REV | TMO REV | ROK GROSS % | TMO GROSS % | ROK FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.34B | $44.56B | 48.1% | 44.0% | $1.17B | $6.29B |
| FY 2024 | $8.26B | $42.88B | 46.6% | 44.0% | $492.1M | $7.27B |
| FY 2023 | $9.06B | $42.86B | 44.0% | 44.0% | $966.4M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ROK // BETA 1.10
TMO // BETA 0.94